These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 39404324)

  • 1. Enhancing the Efficacy of Active Pharmaceutical Ingredients in Medicinal Plants through Nanoformulations: A Promising Field.
    Chen Y; Tang Y; Li Y; Rui Y; Zhang P
    Nanomaterials (Basel); 2024 Oct; 14(19):. PubMed ID: 39404324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticulate-based drug delivery systems for small molecule anti-diabetic drugs: An emerging paradigm for effective therapy.
    Uppal S; Italiya KS; Chitkara D; Mittal A
    Acta Biomater; 2018 Nov; 81():20-42. PubMed ID: 30268916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanosuspensions: Enhancing drug bioavailability through nanonization.
    Chavhan R
    Ann Pharm Fr; 2024 Jun; ():. PubMed ID: 38945393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosize drug delivery system.
    Mukherjee B
    Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal Nanoformulations for Asthma Treatment.
    Yang J; Song B; Wu J
    Curr Pharm Des; 2022; 28(1):46-57. PubMed ID: 34587880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.
    Kumar A; Chen F; Mozhi A; Zhang X; Zhao Y; Xue X; Hao Y; Zhang X; Wang PC; Liang XJ
    Nanoscale; 2013 Sep; 5(18):8307-8325. PubMed ID: 23860639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine and Addictive Disorders: A New Approach With Cannabinoids.
    Giménez VMM; Menéndez SG; Manucha W
    Curr Pharm Des; 2022; 28(34):2795-2799. PubMed ID: 36082864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress of Plant Active Ingredients in Pharmaceutical Cocrystal.
    Wang Z; Shang H; Gao L; Qiao N
    Curr Drug Deliv; 2023; 20(10):1405-1424. PubMed ID: 35993478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving on Nature: The Role of Nanomedicine in the Development of Clinical Natural Drugs.
    Bilia AR; Piazzini V; Guccione C; Risaliti L; Asprea M; Capecchi G; Bergonzi MC
    Planta Med; 2017 Mar; 83(5):366-381. PubMed ID: 28178749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanosuspension-Based Drug Delivery Systems for Topical Applications.
    Aldeeb MME; Wilar G; Suhandi C; Elamin KM; Wathoni N
    Int J Nanomedicine; 2024; 19():825-844. PubMed ID: 38293608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin nanomedicine: a road to cancer therapeutics.
    Yallapu MM; Jaggi M; Chauhan SC
    Curr Pharm Des; 2013; 19(11):1994-2010. PubMed ID: 23116309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Utilization of Plant-Material-Loaded Vesicular Drug Delivery Systems in the Management of Pulmonary Diseases.
    Lukhele BS; Bassey K; Witika BA
    Curr Issues Mol Biol; 2023 Dec; 45(12):9985-10017. PubMed ID: 38132470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.
    Petrovic S; Bita B; Barbinta-Patrascu ME
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing therapy with nano-based delivery systems: exploring the bioactive properties and effects of apigenin.
    Kumar G; Jain P; Virmani T; Sharma A; Akhtar MS; Aldosari SA; Khan MF; Duarte SOD; Fonte P
    Ther Deliv; 2024; 15(9):717-735. PubMed ID: 39259258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Nanoformulations in the Treatment of Neuropsychiatric Diseases: An Approach to Overcome the Blood Brain Barrier.
    Rehman S; Nabi B; Pottoo FH; Baboota S; Ali J
    Curr Drug Metab; 2020; 21(9):674-684. PubMed ID: 32593280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
    Bhattacharjee S; Brayden DJ
    Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal Nanoformulations for Diabetes: Mechanisms, Formulations, and Clinical Impact.
    Sunita M; Kaushik R; Verma KK; Parveen R
    Curr Diabetes Rev; 2024 Mar; ():. PubMed ID: 38500279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing therapeutic efficacy: nanovesicular delivery systems for medicinal plant-based therapeutics.
    Saadh MJ; Mustafa MA; Kumar S; Gupta P; Pramanik A; Rizaev JA; Shareef HK; Alubiady MHS; Al-Abdeen SHZ; Shakier HG; Alaraj M; Alzubaidi LH
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7229-7254. PubMed ID: 38700796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine for the effective and safe delivery of non-steroidal anti-inflammatory drugs: A review of preclinical research.
    Al-Lawati H; Binkhathlan Z; Lavasanifar A
    Eur J Pharm Biopharm; 2019 Sep; 142():179-194. PubMed ID: 31233861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced drug delivery to the lymphatic system: lipid-based nanoformulations.
    Ali Khan A; Mudassir J; Mohtar N; Darwis Y
    Int J Nanomedicine; 2013; 8():2733-44. PubMed ID: 23926431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.